Fennec Pharmaceuticals Inc.

FENC · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$0-$16-$24-$17
Dep. & Amort.$1$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$5$5$4$4
Change in WC-$7-$8-$1-$0
Other Non-Cash$29$1$2-$1
Operating Cash Flow$27-$17-$18-$14
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0$0$0
Financing Activities
Debt Repay.-$13$5$20$5
Stock Issued$0$0$0$0
Stock Repurch.-$0-$0-$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$0$2$1-$0
Financing Cash Flow-$14$7$21$5
Forex Effect$0$0$0$0
Net Chg. in Cash$13-$11$3-$9
Supplemental Information
Beg. Cash$13$24$21$30
End Cash$27$13$24$21
Free Cash Flow$27-$17-$18-$14
Fennec Pharmaceuticals Inc. (FENC) Financial Statements & Key Stats | AlphaPilot